BOK Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4
Closed -$283 1170
2025
Q1
$283 Hold
4
﹤0.01% 1255
2024
Q4
$270 Buy
+4
New +$268 ﹤0.01% 1269
2024
Q3
Sell
-375
Closed -$30.9K 1386
2024
Q2
$30.9K Buy
+375
New +$31.2K ﹤0.01% 898
2023
Q3
Sell
-375
Closed -$32.5K 1193
2023
Q2
$32.5K Sell
375
-315
-46% -$29.6K ﹤0.01% 836
2023
Q1
$67.1K Buy
+690
New +$71.5K ﹤0.01% 807
2021
Q1
$1.07M Buy
14,214
+331
+2% +$27K 0.02% 530
2020
Q4
$1.22M Buy
13,883
+1,380
+11% +$109K 0.02% 474
2020
Q3
$951K Sell
12,503
-5,869
-32% -$594K 0.02% 476
2020
Q2
$2.27M Buy
18,372
+1,132
+7% +$113K 0.05% 296
2020
Q1
$1.46M Sell
17,240
-5,444
-24% -$469K 0.04% 353
2019
Q4
$1.92M Sell
22,684
-10,542
-32% -$796K 0.04% 365
2019
Q3
$2.24M Buy
33,226
+1,638
+5% +$126K 0.05% 328
2019
Q2
$2.71M Sell
31,588
-11,291
-26% -$966K 0.07% 290
2019
Q1
$3.81M Buy
42,879
+8,565
+25% +$794K 0.09% 234
2018
Q4
$2.92M Sell
34,314
-10,096
-23% -$960K 0.08% 247
2018
Q3
$4.31M Buy
44,410
+29,743
+203% +$2.97M 0.11% 230
2018
Q2
$1.38M Buy
+14,667
New +$1.28M 0.04% 422
2017
Q3
Sell
-20,310
Closed -$1.84M 1134
2017
Q2
$1.84M Sell
20,310
-4,035
-17% -$367K 0.06% 336
2017
Q1
$2.14M Sell
24,345
-11,378
-32% -$1.01M 0.07% 303
2016
Q4
$2.96M Buy
35,723
+8,063
+29% +$693K 0.1% 231
2016
Q3
$2.56M Sell
27,660
-1,931
-7% -$182K 0.08% 272
2016
Q2
$2.3M Buy
29,591
+15,337
+108% +$1.3M 0.08% 277
2016
Q1
$1.18M Sell
14,254
-6,912
-33% -$562K 0.04% 400
2015
Q4
$2.22M Sell
21,166
-168
-0.8% -$17.5K 0.08% 287
2015
Q3
$2.25M Sell
21,334
-5,471
-20% -$731K 0.08% 270
2015
Q2
$3.67M Buy
26,805
+1,309
+5% +$162K 0.12% 190
2015
Q1
$3.18M Buy
25,496
+4,134
+19% +$438K 0.11% 225
2014
Q4
$1.93M Sell
21,362
-13,116
-38% -$1.09M 0.07% 306
2014
Q3
$2.49M Sell
34,478
-6,457
-16% -$424K 0.08% 259
2014
Q2
$2.55M Buy
40,935
+9,402
+30% +$568K 0.08% 268
2014
Q1
$2.15M Buy
31,533
+151
+0.5% +$11.1K 0.07% 297
2013
Q4
$2.21M Buy
+31,382
New +$2.13M 0.07% 275

Other funds holding BMRN